You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adenosquamous cell lung cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Subjects Treated With Autologous T Cells Using Sleeping Beauty

Not yet recruiting
  • Gynecologic Cancer
  • +9 more
  • Neoantigen specific TCR-T cell drug product
  • Houston, Texas
    MD Anderson Cancer Center
Jul 27, 2022

Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Houston (Neoantigen specific TCR-T cell drug product,

Recruiting
  • Gynecologic Cancer
  • +11 more
  • Neoantigen specific TCR-T cell drug product
  • Aldesleukin (IL-2)
  • Houston, Texas
    MD Anderson Cancer Center
Jul 27, 2022

Sputum DNA Testing for Lung Cancer in China

Recruiting
  • Lung Cancer
  • +15 more
  • Diagnostic Test: Sputum DNA methylation analysis
  • chest CT or pathological examination
  • Guangzhou, Guangdong, China
    Nanfang Hospital of Southern Medccal University
Dec 29, 2022

Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Large Cell Lung Cancer Trial in Los Angeles (radiation, other, drug)

Active, not recruiting
  • Adenocarcinoma of the Lung
  • +8 more
  • hypofractionated radiation therapy
  • +5 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Dec 2, 2021

Lung Tumors, Squamous Cell Lung Cancer, Adenocarcinoma of the Lung Trial in Guangzhou (Icotinib)

Recruiting
  • Lung Neoplasms
  • +6 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 29, 2021

Advanced Lung Adenocarcinoma, Advanced Lung Adenosquamous Carcinoma, Advanced Lung Non-Small Cell Carcinoma Trial in United

Recruiting
  • Advanced Lung Adenocarcinoma
  • +10 more
  • Phoenix, Arizona
  • +98 more
Feb 2, 2023

Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer Trial in United States (dietary

Completed
  • Adenocarcinoma of the Lung
  • +7 more
  • soy isoflavones
  • +4 more
  • Bay City, Michigan
  • +4 more
Nov 19, 2020

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

Not yet recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Nab paclitaxel
  • +5 more
  • (no location specified)
Oct 30, 2023

Double-dose Furmonertinib in Treatment of Slow

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • (no location specified)
Oct 31, 2023

NSCLC Trial in Shanghai

Not yet recruiting
  • Non-small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Jul 20, 2023

    Non-small Cell Lung Cancer With Central Nervous System

    Recruiting
    • Lung Cancer With Central Nervous System Metastasis
    • lung cancer with brain /leptomeningeal metastasis
    • Taipei, Taiwan
      National Taiwan University Hospital
    Sep 4, 2023

    NSCLC, EGFR Gene Mutation, EGFR-TKI Resistant Mutation Trial (Nintedanib, gefitinib, erlotinib, afatinib)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +2 more
    • Nintedanib, gefitinib, erlotinib, afatinib
    • (no location specified)
    Oct 2, 2023

    NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)

    Recruiting
    • Non-small Cell Lung Cancer
    • +3 more
    • Yangzhou, Jiangsu, China
      People's hospital of northern jiangsu
    Sep 26, 2023

    HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy Trial in New Brunswick (Conditioning, E7 TCR-T

    Not yet recruiting
    • HPV-Associated Cervical Carcinoma
    • +16 more
    • Conditioning, E7 TCR-T cells, and aldesleukin
    • New Brunswick, New Jersey
      Rutgers Cancer Institute of New Jersey
    Jan 17, 2023

    Extensive Stage Small Cell Lung Cancer (ES-SCLC) Trial (HS-20093)

    Not yet recruiting
    • Extensive Stage Small Cell Lung Cancer (ES-SCLC)
    • (no location specified)
    Sep 19, 2023

    TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

    Not yet recruiting
    • Lung Cancer, Non-small Cell
    • Small Cell Lung Cancer
      • (no location specified)
      Nov 16, 2022

      Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas Trial in Boston (ZIMBERELIMAB,

      Recruiting
      • Pancreatic Cancer
      • +3 more
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Jan 9, 2023

      Specific Protein Overexpression in Adult Non-Small Cell Lung

      Not yet recruiting
      • Non Small Cell Lung Cancer
        • (no location specified)
        Sep 29, 2023

        Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

        Recruiting
        • Small Cell Lung Cancer
        • Biospecimen Collection
        • Indianapolis, Indiana
        • +1 more
        Jun 2, 2023

        Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

        Recruiting
        • Nonsmall Cell Lung Cancer
        • +3 more
        • Genomically Guided Radiation Therapy (RT)
        • Tampa, Florida
          Moffitt Cancer Center
        May 23, 2023

        Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)

        Not yet recruiting
        • Relapsed Small Cell Lung Cancer
        • Irinotecan hydrochloride liposome Injection
        • Topotecan
        • Beijing, China
          Cancer Hospital, Chinese Academy of Medical Sciences
        Nov 7, 2023

        Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

        Not yet recruiting
        • Metastatic Lung Non-Small Cell Carcinoma
        • +2 more
        • Cetuximab
        • +2 more
        • Sacramento, California
          University of California Davis Comprehensive Cancer Center
        Oct 2, 2023

        Stage II-IIIB(N2) NSCLC Trial in Shanghai (TQB2450, Carboplatin, Pemetrexed)

        Not yet recruiting
        • Stage II-IIIB(N2) Non-small Cell Lung Cancer
        • Shanghai, Shanghai, China
          Shanghai Pulmonary Hospital
        Oct 26, 2023

        Extensive Stage Small Cell Lung Cancer Trial (hSTC810 400 mg + Paclitaxel, hSTC810 800 mg + Paclitaxel)

        Not yet recruiting
        • Extensive Stage Small Cell Lung Cancer
        • hSTC810 400 mg + Paclitaxel
        • hSTC810 800 mg + Paclitaxel
        • (no location specified)
        Aug 24, 2023

        Identify Resected Non-small-cell Lung Cancer With High Risk of

        Recruiting
        • Non-small Cell Lung Cancer Stage IIIA
        • Resected non small cell lung cancer
        • Toulouse, France
          Julien MAZIERES
        Feb 8, 2023